| Year |
Citation |
Score |
| 2020 |
Samarasimhareddy M, Shamir M, Shalev DE, Hurevich M, Friedler A. A Rapid and Efficient Building Block Approach for Click Cyclization of Peptoids. Frontiers in Chemistry. 8: 405. PMID 32509731 DOI: 10.3389/Fchem.2020.00405 |
0.403 |
|
| 2019 |
Nir S, Zanuy D, Zada T, Agazani O, Aleman C, Shalev DE, Reches M. Tailoring the self-assembly of a tripeptide for the formation of antimicrobial surfaces. Nanoscale. 11: 8752-8759. PMID 30778487 DOI: 10.1039/C8Nr10043H |
0.36 |
|
| 2016 |
Shoshan MS, Dekel N, Goch W, Shalev DE, Danieli T, Lebendiker M, Bal W, Tshuva EY. Unbound position II in MXCXXC metallochaperone model peptides impacts metal binding mode and reactivity: Distinct similarities to whole proteins. Journal of Inorganic Biochemistry. 159: 29-36. PMID 26901629 DOI: 10.1016/J.Jinorgbio.2016.02.016 |
0.397 |
|
| 2014 |
Chandra K, Roy TK, Shalev DE, Loyter A, Gilon C, Gerber RB, Friedler A. A tandem in situ peptide cyclization through trifluoroacetic acid cleavage. Angewandte Chemie (International Ed. in English). 53: 9450-5. PMID 24827640 DOI: 10.1002/Anie.201402789 |
0.412 |
|
| 2014 |
Chandra K, Roy TK, Shalev DE, Loyter A, Gilon C, Gerber RB, Friedler A. Frontispiece: A Tandem In Situ Peptide Cyclization through Trifluoroacetic Acid Cleavage Angewandte Chemie International Edition. 53: n/a-n/a. DOI: 10.1002/Anie.201483671 |
0.375 |
|
| 2013 |
Shoshan MS, Tshuva EY, Shalev DE. Structure and coordination determination of peptide-metal complexes using 1D and 2D ¹H NMR. Journal of Visualized Experiments : Jove. e50747. PMID 24378924 DOI: 10.3791/50747 |
0.376 |
|
| 2013 |
Hurevich M, Ratner-Hurevich M, Tal-Gan Y, Shalev DE, Ben-Sasson SZ, Gilon C. Backbone cyclic helix mimetic of chemokine (C-C motif) receptor 2: a rational approach for inhibiting dimerization of G protein-coupled receptors. Bioorganic & Medicinal Chemistry. 21: 3958-66. PMID 23706536 DOI: 10.1016/J.Bmc.2013.03.019 |
0.36 |
|
| 2013 |
Shoshan MS, Shalev DE, Tshuva EY. Peptide models of Cu(I) and Zn(II) metallochaperones: the effect of pH on coordination and mechanistic implications. Inorganic Chemistry. 52: 2993-3000. PMID 23458158 DOI: 10.1021/Ic302404W |
0.396 |
|
| 2013 |
Ben-Shimon A, Shalev DE, Niv MY. Protonation States in molecular dynamics simulations of peptide folding and binding. Current Pharmaceutical Design. 19: 4173-81. PMID 23170889 DOI: 10.2174/1381612811319230003 |
0.414 |
|
| 2013 |
Shoshan M, Shalev D, Tshuva E. MDCSGCSRPG head-to-tail cyclic peptide + Cu(I) no metal constraint - high energy ensemble (B) Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.13018/Bmr21023 |
0.32 |
|
| 2012 |
Gabizon R, Brandt T, Sukenik S, Lahav N, Lebendiker M, Shalev DE, Veprintsev D, Friedler A. Specific recognition of p53 tetramers by peptides derived from p53 interacting proteins. Plos One. 7: e38060. PMID 22693587 DOI: 10.1371/Journal.Pone.0038060 |
0.423 |
|
| 2012 |
Hayouka Z, Levin A, Hurevich M, Shalev DE, Loyter A, Gilon C, Friedler A. A comparative study of backbone versus side chain peptide cyclization: application for HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry. 20: 3317-22. PMID 22507205 DOI: 10.1016/J.Bmc.2012.03.039 |
0.418 |
|
| 2012 |
Scherzer-Attali R, Farfara D, Cooper I, Levin A, Ben-Romano T, Trudler D, Vientrov M, Shaltiel-Karyo R, Shalev DE, Segev-Amzaleg N, Gazit E, Segal D, Frenkel D. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model. Neurobiology of Disease. 46: 663-72. PMID 22449754 DOI: 10.1016/J.Nbd.2012.03.005 |
0.328 |
|
| 2011 |
Reingewertz TH, Shalev DE, Sukenik S, Blatt O, Rotem-Bamberger S, Lebendiker M, Larisch S, Friedler A. Mechanism of the interaction between the intrinsically disordered C-terminus of the pro-apoptotic ARTS protein and the Bir3 domain of XIAP. Plos One. 6: e24655. PMID 21949740 DOI: 10.1371/Journal.Pone.0024655 |
0.351 |
|
| 2011 |
Frydman-Marom A, Convertino M, Pellarin R, Lampel A, Shaltiel-Karyo R, Segal D, Caflisch A, Shalev DE, Gazit E. Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue. Acs Chemical Biology. 6: 1265-76. PMID 21892833 DOI: 10.1021/Cb200103H |
0.395 |
|
| 2011 |
Tal-Gan Y, Hurevich M, Klein S, Ben-Shimon A, Rosenthal D, Hazan C, Shalev DE, Niv MY, Levitzki A, Gilon C. Backbone cyclic peptide inhibitors of protein kinase B (PKB/Akt). Journal of Medicinal Chemistry. 54: 5154-64. PMID 21650457 DOI: 10.1021/Jm2003969 |
0.416 |
|
| 2011 |
Shoshan MS, Shalev DE, Adriaens W, Merkx M, Hackeng TM, Tshuva EY. NMR characterization of a Cu(I)-bound peptide model of copper metallochaperones: insights on the role of methionine. Chemical Communications (Cambridge, England). 47: 6407-9. PMID 21552638 DOI: 10.1039/C1Cc11600B |
0.327 |
|
| 2010 |
Shaltiel-Karyo R, Frenkel-Pinter M, Egoz-Matia N, Frydman-Marom A, Shalev DE, Segal D, Gazit E. Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies. Plos One. 5: e13863. PMID 21085664 DOI: 10.1371/Journal.Pone.0013863 |
0.435 |
|
| 2010 |
Hayouka Z, Hurevich M, Levin A, Benyamini H, Iosub A, Maes M, Shalev DE, Loyter A, Gilon C, Friedler A. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein. Bioorganic & Medicinal Chemistry. 18: 8388-95. PMID 20974536 DOI: 10.1016/J.Bmc.2010.09.046 |
0.446 |
|
| 2010 |
Scherzer-Attali R, Pellarin R, Convertino M, Frydman-Marom A, Egoz-Matia N, Peled S, Levy-Sakin M, Shalev DE, Caflisch A, Gazit E, Segal D. Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor. Plos One. 5: e11101. PMID 20559435 DOI: 10.1371/Journal.Pone.0011101 |
0.344 |
|
| 2010 |
Reingewertz TH, Shalev DE, Friedler A. Structural disorder in the HIV-1 Vif protein and interaction-dependent gain of structure. Protein and Peptide Letters. 17: 988-98. PMID 20450485 DOI: 10.2174/092986610791498876 |
0.356 |
|
| 2010 |
Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A. Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370. Biochemical and Biophysical Research Communications. 394: 260-5. PMID 20171172 DOI: 10.1016/J.Bbrc.2010.02.100 |
0.347 |
|
| 2010 |
Ronen D, Rosenberg MM, Shalev DE, Rosenberg M, Rotem S, Friedler A, Ravid S. The positively charged region of the myosin IIC non-helical tailpiece promotes filament assembly. The Journal of Biological Chemistry. 285: 7079-86. PMID 19959848 DOI: 10.1074/Jbc.M109.049221 |
0.346 |
|
| 2009 |
Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds. Bioorganic & Medicinal Chemistry. 17: 7635-42. PMID 19850483 DOI: 10.1016/J.Bmc.2009.09.053 |
0.388 |
|
| 2009 |
Reingewertz TH, Benyamini H, Lebendiker M, Shalev DE, Friedler A. The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state. Protein Engineering, Design & Selection : Peds. 22: 281-7. PMID 19218568 DOI: 10.1093/Protein/Gzp004 |
0.41 |
|
| 2009 |
Qvit N, Hatzubai A, Shalev DE, Friedler A, Ben-Neriah Y, Gilon C. Design and synthesis of backbone cyclic phosphorylated peptides: The IkappaB model. Biopolymers. 91: 157-68. PMID 19025995 DOI: 10.1002/Bip.21098 |
0.424 |
|
| 2008 |
Katz C, Benyamini H, Rotem S, Lebendiker M, Danieli T, Iosub A, Refaely H, Dines M, Bronner V, Bravman T, Shalev DE, Rüdiger S, Friedler A. Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2. Proceedings of the National Academy of Sciences of the United States of America. 105: 12277-82. PMID 18719108 DOI: 10.1073/Pnas.0711269105 |
0.402 |
|
| 2008 |
Linde Y, Ovadia O, Safrai E, Xiang Z, Portillo FP, Shalev DE, Haskell-Luevano C, Hoffman A, Gilon C. Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides. Biopolymers. 90: 671-82. PMID 18655141 DOI: 10.1002/Bip.21057 |
0.387 |
|
| 2008 |
Qvit N, Monderer-Rothkoff G, Ido A, Shalev DE, Amster-Choder O, Gilon C. Development of bifunctional photoactivatable benzophenone probes and their application to glycoside substrates. Biopolymers. 90: 526-36. PMID 18459171 DOI: 10.1002/Bip.21010 |
0.322 |
|
| 2008 |
Levy M, Porat Y, Bacharach E, Shalev DE, Gazit E. Phenolsulfonphthalein, but not phenolphthalein, inhibits amyloid fibril formation: implications for the modulation of amyloid self-assembly. Biochemistry. 47: 5896-904. PMID 18457421 DOI: 10.1021/Bi800043D |
0.332 |
|
| 2008 |
Qvit N, Reuveni H, Gazal S, Zundelevich A, Blum G, Niv MY, Feldstein A, Meushar S, Shalev DE, Friedler A, Gilon C. Synthesis of a novel macrocyclic library: discovery of an IGF-1R inhibitor. Journal of Combinatorial Chemistry. 10: 256-66. PMID 18271560 DOI: 10.1021/Cc700113C |
0.351 |
|
| 2008 |
Hess S, Linde Y, Ovadia O, Safrai E, Shalev DE, Swed A, Halbfinger E, Lapidot T, Winkler I, Gabinet Y, Faier A, Yarden D, Xiang Z, Portillo FP, Haskell-Luevano C, et al. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. Journal of Medicinal Chemistry. 51: 1026-34. PMID 18220330 DOI: 10.1021/Jm701093Y |
0.313 |
|
| 2008 |
Gabizon R, Mor M, Rosenberg MM, Britan L, Hayouka Z, Kotler M, Shalev DE, Friedler A. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat. Biopolymers. 90: 105-16. PMID 18189286 DOI: 10.1002/Bip.20919 |
0.389 |
|
| 2007 |
Hess S, Ovadia O, Shalev DE, Senderovich H, Qadri B, Yehezkel T, Salitra Y, Sheynis T, Jelinek R, Gilon C, Hoffman A. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability. Journal of Medicinal Chemistry. 50: 6201-11. PMID 17983214 DOI: 10.1021/Jm070836D |
0.393 |
|
| 2006 |
Carny O, Shalev DE, Gazit E. Fabrication of coaxial metal nanocables using a self-assembled peptide nanotube scaffold. Nano Letters. 6: 1594-7. PMID 16895341 DOI: 10.1021/Nl060468L |
0.356 |
|
| 2006 |
Rosenbluh J, Kapelnikov A, Shalev DE, Rusnati M, Bugatti A, Loyter A. Positively charged peptides can interact with each other, as revealed by solid phase binding assays. Analytical Biochemistry. 352: 157-68. PMID 16581010 DOI: 10.1016/J.Ab.2006.03.002 |
0.405 |
|
| 2006 |
Shalev DE, Rotem S, Fish A, Mor A. Consequences of N-acylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13). The Journal of Biological Chemistry. 281: 9432-8. PMID 16407175 DOI: 10.1074/Jbc.M513051200 |
0.341 |
|
| 2003 |
Shalev DE, Yerushalmi Y, Pener MP, Kustanovich I. Nuclear magnetic resonance (NMR) studies of the dark-color-inducing neurohormone of locusts and corazonin. Insect Biochemistry and Molecular Biology. 33: 489-497. PMID 12706628 DOI: 10.1016/S0965-1748(03)00020-1 |
0.423 |
|
| 2002 |
Shalev DE, Mor aA, Kustanovich I. Structural consequences of carboxyamidation of dermaseptin S3. Biochemistry. 41: 7312-7317. PMID 12044162 DOI: 10.1021/Bi016013M |
0.412 |
|
| 2002 |
Kustanovich I, Shalev DE, Mikhlin M, Gaidukov L, Mor A. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. The Journal of Biological Chemistry. 277: 16941-51. PMID 11847217 DOI: 10.1074/Jbc.M111071200 |
0.432 |
|
| 1996 |
Fraenkel Y, Shalev DE, Gershoni JM, Navon G. Nuclear magnetic resonance (NMR) analysis of ligand receptor interactions: the cholinergic system--a model. Critical Reviews in Biochemistry and Molecular Biology. 31: 273-301. PMID 8877268 DOI: 10.3109/10409239609106586 |
0.499 |
|
| Show low-probability matches. |